Real World Evidence Solutions Market: Lack of Universally Accepted MethodologicaPosted by Kriti on May 24th, 2021 The research study involves Top-down and bottom-up approaches were used to validate the size of Real World Evidence Solutions industry and estimate the size of other dependent submarkets. Various secondary sources such as directories, industry journals, databases such as D&B Hoovers, Bloomberg Business, and Factiva, and annual reports of the companies have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market. Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=76173991 Major Market Growth Drivers: Revenue Growth Analysis: Based on therapeutic area, the oncology segment accounted for the largest share of the real-world evidence market in 2017. The large share of this segment can be attributed to the high number of clinical trials conducted for oncology and the rising prevalence of cancer worldwide. By end user, the pharmaceutical & medical device companies segment held the largest market share of the real world evidence market in 2017. Based on end user, the pharmaceutical & medical device companies segment accounted for the largest share of the real world evidence market. The large share of this segment can be attributed to the increasing importance of RWE studies in drug approvals, the need to prevent costly drug recalls, and the increasing need to assess drug performance in real-world settings. North America dominated the market in 2017. North America accounted for the largest share of the real world evidence market in 2017, followed by Europe and Asia Pacific. Presence of a favorable regulatory environment, high number of RWE service providers, the presence of a well-established pharmaceutical industry in the region, coupled with the high R&D expenditure, are the major factors responsible for the large share of North America in the global real world evidence market. To speak to our analyst for a discussion on the above findings, click Speak to Analyst Key Market Players: Like it? Share it!More by this author |